.
MergerLinks Header Logo

Announced

3D Systems to acquire Volumetric Biotechnologies for up to $400m.

Financials

Edit Data
Transaction Value£290m
Consideration TypeCash, Contingent Deferred Consideration
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Majority

Domestic

United States

biotechnology company

Pending

Single Bidder

Biotechnology

Acquisition

Private

Friendly

Synopsis

Edit

3D Systems, a company that engineers, manufactures and sells 3D printers, 3D printing materials, 3D scanners, and offers a 3D printing service, agreed to acquire Volumetric Biotechnologies, a Houston-based biotech company, for up to $400m. "The addition of Dr. Miller and his exceptional team of researchers to our existing Team, led by our Chief Technology Officer for Regenerative Medicine, Chuck Hull, will dramatically expand our capabilities and capacity for the development of bioprinted human organs," Jeffrey Graves, 3D Systems President and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US